APRINOIA THERAPEUTICS INC.
Update：2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
APRINOIA THERAPEUTICS INC. is dedicated to the research and development of world-class diagnostic technologies and therapeutics for Alzheimer's disease (AD) and other Tau protein-related neurodegenerative diseases (tauopathies).
The content above was translated by Ai
Founded Year
2015
Unified Business No.
24969508
Status
Closed
Number of Employees
0
Total Paid-in
Capital
- (NT$)
Location of Company
Taiwan
, Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
APRINOIA is a biotechnology company with a deep research foundation, dedicated to providing best-in-class diagnostic tools and novel therapies, improving the treatment outcomes of various neurodegenerative diseases, and protecting patients' brain health.
The English name of APRINOIA, "APRINOIA", is a combination of the Latin word "apricum", which symbolizes sunshine, and the Greek suffix "noia", which means "mind". The company name highlights our mission: in the face of dreadful neurodegenerative diseases, we actively explore the path of developing better diagnostic and therapeutic drugs to realize the company's vision of utilizing these novel diagnostic tools and targeted therapeutic drugs to provide a better future for patients.
The English name of APRINOIA, "APRINOIA", is a combination of the Latin word "apricum", which symbolizes sunshine, and the Greek suffix "noia", which means "mind". The company name highlights our mission: in the face of dreadful neurodegenerative diseases, we actively explore the path of developing better diagnostic and therapeutic drugs to realize the company's vision of utilizing these novel diagnostic tools and targeted therapeutic drugs to provide a better future for patients.
The content above was translated by Ai
